CN Mobile Logo

Search form


Oncology and Hematology News and Journal Articles

Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages

This article reviews the rationale for nanoparticle formulations of existing or previously investigated cytotoxic drugs, describe currently approved nanoparticle formulations of drugs, and discusses some of the most promising clinical trials currently underway.

Recent Content

A novel calculator can more easily identify which esophageal adenocarcinoma patients derive an overall survival benefit from neoadjuvant chemoradiation to help guide treatment choices.

This video examines research that found that certain genetic variations of both leukemia patients undergoing bone marrow transplant and their unrelated donors were associated with poor outcomes.

A 67-year-old man presents with gastric pain, and a biopsy is performed. What is your diagnosis?

No difference in time to recurrence, recurrence-free survival, or overall survival were noted for patients with rectal cancer who underwent one of three different preoperative radiotherapy regimens.

This video highlights some of the latest developments guiding precision medicine for lung cancer in clinical practice.

A study of the combination of radiation therapy and immune checkpoint inhibitors for the treatment of advanced lung cancer found a modest risk of side effects.

In this interview we discuss how quality-of-life information from patients with lung cancer can be used to help guide treatment and inform outcomes.

By clicking Accept, you agree to become a member of the UBM Medica Community.